Coronavirus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

SA55 Novel Coronavirus Broad-spectrum Neutralizing Antibody Nasal Spray in Health People
Condition:   COVID-19 Intervention:   Drug: SA55 nasal spray Sponsor:   Sinovac Life Sciences Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Omicron BA.4/5-Delta COVID-19 Vaccine Phase I Clinical Trial
Condition:   COVID-19 Interventions:   Biological: Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells);   Biological: Placebo Sponsors:   Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.;   Hunan Provincial Center for Disease Control and Prevention Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

SA55 Novel Coronavirus Broad-spectrum Neutralizing Antibody Nasal Spray in Health People
Condition:   COVID-19 Intervention:   Drug: SA55 nasal spray Sponsor:   Sinovac Life Sciences Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Omicron BA.4/5-Delta COVID-19 Vaccine Phase I Clinical Trial
Conditions: COVID-19 Interventions: Biological: Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells); Biological: Placebo Sponsors: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.; Hunan Provincial Center for Disease Control and Prevention Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure
Conditions:   COVID-19;   Hypoxemic Respiratory Failure Intervention:   Device: High flow nasal oxygen (HFNO, more than 15 L/min) Sponsor:   Amsterdam UMC, location VUmc Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Evaluation of Safety and Immunogenicity of a SARS-CoV-2(Severe Acute Respiratory Syndrome Coronavirus 2) Booster Vaccine (LEM-mR203)
Conditions:   COVID-19 Infection;   COVID-19 Vaccine Adverse Reaction Interventions:   Biological: LEM-mR203;   Biological: Placebo Sponsor:   Lemonex Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2023 Category: Research Source Type: clinical trials